Zafgen Inc (NASDAQ:ZFGN) announced its third quarter 2016 financial results. “We have leveraged our experience with the MetAP2 pathway to develop ZGN-1061, a …
Zafgen Inc (NASDAQ:ZFGN) announced that the Company has recently initiated dosing in the multiple ascending dose (MAD) cohorts of its ongoing Phase 1 clinical …
Zafgen Inc (NASDAQ:ZFGN) is shooting for a refocus after an FDA meeting has led to suspension of future development for weight loss agent …
Analyst Phil Nadeau of Cowen downgraded shares of Zafgen Inc (NASDAQ:ZFGN) from Outperform to Market Perform, after the biotech company terminated one of its pipeline drugs, …
Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, announced …
Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today …
Healthcare analysts explain why they are bullish on Allergan plc Ordinary Shares (NYSE:AGN) and Zafgen Inc (NASDAQ:ZFGN). Although many investors are worried that …
Zafgen Inc (NASDAQ:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, …
Seadrill Ltd (NYSE:SDRL) is down 4% in pre-market trading following news that it is in talks with various firms to restructure loans and …